Using murine knockout models, GPER overexpression and localization in the plasma membrane have been shown to be essential events for breast cancer progression [80]; its absence in the plasma membrane has been reported to have an excellent long-term prognosis for ERα+ breast cancer patients treated with tamoxifen [78]. The gene discussed is GPER1; the disease is breast carcinoma.